Annual Drug Patent Expiration for SUNOSI
Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.
SUNOSI drug price trends.
This drug has forty-four patent family members in twenty countries.
The generic ingredient in SUNOSI is solriamfetol hydrochloride. Two registered suppliers for this compound. Additional details are available on the solriamfetol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New Patent for the SUNOSI Malta drug Axsome